Pages that link to "Q46639360"
Jump to navigation
Jump to search
The following pages link to Severe eczema vaccinatum in a household contact of a smallpox vaccinee (Q46639360):
Displaying 50 items.
- Are we there yet? The smallpox research agenda using variola virus (Q21131362) (← links)
- Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected Patient (Q21558605) (← links)
- Human Monkeypox (Q27023061) (← links)
- Principles of antidote pharmacology: an update on prophylaxis, post‐exposure treatment recommendations and research initiatives for biological agents (Q28384852) (← links)
- Comparison of the Safety and Pharmacokinetics of ST-246® after IV Infusion or Oral Administration in Mice, Rabbits and Monkeys (Q28741437) (← links)
- Orthopox Viruses: Infections in Humans (Q28742218) (← links)
- Study of camelpox virus pathogenesis in athymic nude mice (Q28743156) (← links)
- Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201) (Q28743894) (← links)
- Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment (Q30228429) (← links)
- Clinical experience, infection control practices and diagnostic algorithms for poxvirus infections - an Emerging Infections Network survey (Q33534474) (← links)
- A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection (Q33573571) (← links)
- Vaccinia virus-specific molecular signature in atopic dermatitis skin (Q33621491) (← links)
- Recent insights into atopic dermatitis and implications for management of infectious complications (Q33621496) (← links)
- Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus (Q33895494) (← links)
- Molluscum contagiosum in a pediatric American Indian population: incidence and risk factors (Q33968435) (← links)
- The infectious aspects of atopic dermatitis (Q34032522) (← links)
- Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread (Q34420319) (← links)
- Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy (Q34432037) (← links)
- Postexposure Prevention of Progressive Vaccinia in SCID Mice Treated with Vaccinia Immune Globulin (Q34484027) (← links)
- Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice (Q34502253) (← links)
- Atopic dermatitis in children: clinical features, pathophysiology, and treatment (Q34625597) (← links)
- Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. (Q34663953) (← links)
- Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes. (Q34714569) (← links)
- Smallpox vaccine safety is dependent on T cells and not B cells (Q34743303) (← links)
- Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity (Q34762818) (← links)
- Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response (Q34781786) (← links)
- Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice (Q34922842) (← links)
- Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless mice (Q35007525) (← links)
- Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses (Q35023470) (← links)
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulation (Q35065037) (← links)
- Development of the Small-Molecule Antiviral ST-246 ® as a Smallpox Therapeutic (Q35152092) (← links)
- Development of ST-246® for Treatment of Poxvirus Infections (Q35260385) (← links)
- Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics (Q35261304) (← links)
- Immune modulation in primary vaccinia virus zoonotic human infections (Q35645804) (← links)
- Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone (Q35738585) (← links)
- A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis. (Q35800226) (← links)
- Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections (Q36185647) (← links)
- Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. (Q36486818) (← links)
- Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects (Q36727280) (← links)
- Comorbidity in Atopic Dermatitis (Q36899783) (← links)
- Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3. (Q36949602) (← links)
- Specificity protein 1 is pivotal in the skin’s antiviral response (Q37073740) (← links)
- In vitro efficacy of ST246 against smallpox and monkeypox (Q37115752) (← links)
- ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification (Q37190669) (← links)
- Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. (Q37204210) (← links)
- Progress in the discovery of compounds inhibiting orthopoxviruses in animal models (Q37331541) (← links)
- Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox). (Q37335688) (← links)
- ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation (Q37450819) (← links)
- Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012. (Q37593480) (← links)
- Investigational and Unproven Therapies in Atopic Dermatitis (Q37776588) (← links)